Rad50 promotes ovarian cancer progression through NF‐κB activation

Yinuo Li(Shandong University), Beihua Kong(Shandong University)

Journal of Cellular and Molecular Medicine

November 3, 2021

10.1111/jcmm.17017

Cited by 21

Related Papers

miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma

|Oncology Reports|2014|43

RECQL4, Negatively Regulated by miR-10a-5p, Facilitates Cell Proliferation and Invasion via MAFB in Ovarian Cancer

|Frontiers in Oncology|2020|37

Overexpression of PRC1 indicates a poor prognosis in ovarian cancer

|International Journal of Oncology|2020|34

FBLN5 is targeted by microRNA‑27a‑3p and suppresses tumorigenesis and progression in high‑grade serous ovarian carcinoma

|Oncology Reports|2020|19

Supplementary Figure from Pamiparib Monotherapy for Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study

|Unknown|2023|0